Possible Side Effects of Wegovy: What Most People Experience

Your first few weeks: the nausea question everyone actually asks

Picture this: your Wegovy pen arrives, you follow the instructions, and two days later you feel queasy at the smell of dinner. That reaction is familiar to a significant proportion of people who start semaglutide, and it is worth understanding why it happens rather than simply being warned it might.

Wegovy is a GLP-1 receptor agonist, it activates receptors involved in appetite signalling and slows how quickly food leaves the stomach. That slowing is part of how it reduces hunger. It is also the reason nausea, burping, reflux and a feeling of early fullness are so common at the start of treatment. The symptoms are most noticeable during the first four to eight weeks and after each upward dose step. For most people, they settle without any change to the treatment plan.

Practical things that tend to help: eating smaller portions, avoiding very fatty or strongly spiced meals, staying upright after eating, and keeping well hydrated. If the nausea is severe or persistent rather than background-level, your prescriber should hear about it, adjusting the titration pace is an option. Our full Wegovy side-effects guide covers the complete list of reported effects in more detail.

Vomiting, diarrhoea and constipation sit alongside nausea in the commonly-reported bracket. Constipation in particular can catch people off guard because it tends to appear a little later, once appetite has dropped and dietary fibre intake has fallen. Increasing vegetables, pulses and water intake often resolves it without any intervention.

Side effects that are less common but worth knowing

Beyond the GI effects, some people notice fatigue, headache or dizziness, particularly in the early weeks. These generally resolve as the body adjusts to semaglutide and, where relevant, to eating less overall.

Injection-site reactions (mild redness, itching or a small raised area where the pen was used) are reported by a minority of users. Rotating between the abdomen, thigh and upper arm reduces local irritation. The full detail on rotating and technique is in the Patient Information Leaflet that comes with each pen.

Hair thinning is something a number of people ask about, and it does appear in post-marketing reports. The evidence suggests it is largely related to rapid weight loss rather than the medicine itself, a well-recognised pattern called telogen effluvium. The semaglutide and hair loss page walks through what the evidence actually shows and whether it reverses.

Mood and emotional changes come up in conversations about GLP-1 medicines more broadly. The MHRA has reviewed the available data; the picture is not yet definitive, and it remains an active area of monitoring. If you notice changes in mood or low feelings, that is worth raising with your prescriber promptly. There is a separate page on Wegovy and mood if you want to look at the evidence specifically.

Some effects that get less attention are actually positive, improved energy as weight reduces, and for some people improvements in sleep and blood pressure. The positive side effects of Wegovy page covers these honestly, with the appropriate caveats.

When to get medical help urgently

Most of Wegovy's side effects are manageable and resolve on their own. A few signals require prompt medical attention and should not be left until a routine appointment.

Severe stomach pain (particularly pain that is persistent and radiates through to the back, with or without vomiting) is the symptom associated with acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update confirming pancreatitis as a known, infrequent but potentially serious risk with GLP-1 receptor agonists; if that symptom pattern appears, go to A&E or call 999. Do not wait.

Other situations requiring urgent review: signs of dehydration from prolonged vomiting or diarrhoea (dizziness on standing, very dark urine, inability to keep fluids down); symptoms of a severe allergic reaction (facial swelling, difficulty breathing, rash); and significant changes in mood or thoughts of self-harm.

Gallbladder problems (including gallstones) are reported more often in people who lose weight rapidly on any treatment, including semaglutide. Upper-right abdominal pain, especially after eating, is the sign to watch for. Report it to your GP or prescriber rather than pushing through it.

For a broader look at the serious end of the side-effect spectrum, the bad side effects of Wegovy page covers what is documented in clinical literature and post-marketing surveillance. The MHRA Drug Safety Updates index is the authoritative source for any new regulatory communications on semaglutide.

How prescribers at nume approach side-effect management

Before any treatment begins, a GPhC-registered Independent Prescriber reads your consultation answers (not an algorithm) and considers your health history alongside the known side-effect profile. That includes asking about conditions that would change the risk picture: a personal or family history of certain thyroid conditions, pancreatitis, gallbladder disease, or any GI condition affecting motility.

If you proceed with treatment, aftercare is available seven days a week. Side effects that develop after the first pen, or after a dose increase, are exactly the kind of thing our prescribers are here to hear about. You do not need to wait until a scheduled review to make contact, the contact page explains how to reach the team.

The consultation is also the right moment to ask every question on your list, including ones that feel minor. Questions about the titration schedule, about what to do if a dose is missed, about how Wegovy interacts with other medicines, those belong with your prescriber and the leaflet, not with a search engine. Speak to our prescribers if you want to start that conversation.

For context on cost and what private treatment involves, the Wegovy pricing page explains what is included. And if you are still weighing up whether Wegovy is the right route, the weight-loss treatment overview covers the licensed options available through nume.